<?xml version="1.0" encoding="UTF-8"?>
<p id="p0120"> Pregnant women, especially in middle and terminal pregnancy, are prone to develop into severe patients after infecting with COVID-19.
 <xref rid="bib18" ref-type="bibr">
  <sup>18</sup>
 </xref> Gestational age, and whether to terminate the pregnancy after treatment has been considered in the therapy.
 <xref rid="bib16" ref-type="bibr">
  <sup>16</sup>
 </xref> Older adults are often associated with a variety of chronic diseases and have a higher risk of death if infected with COVID-19.
 <xref rid="bib19" ref-type="bibr">
  <sup>19</sup>
 </xref> Physiological characteristics and combination of drugs will change pharmacokinetics and affect the efficacy. Therefore, individualized pharmaceutical care have been provided in combination with physiological characteristics and disease progression.
 <xref rid="bib20" ref-type="bibr">
  <sup>20</sup>
 </xref>
</p>
